Nrt Smoking Cessation Aids Market Analysis in Brazil Market Overview in Feb-2010 Edition

• Publication date: February 2010

Euromonitor International's NRT Smoking Cessation Aids in Brazil report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the segments driving growth. It identifies the leading firms , the leading brands and offers strategic analysis of key factors influencing the industry - be they new product developments, distribution or pricing...

Euromonitor International's NRT Smoking Cessation Aids in Brazil report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the segments driving growth. It identifies the leading firms , the leading brands and offers strategic analysis of key factors influencing the industry - be they new product developments, distribution or pricing issues. Projections to 2013 illustrate how the industry is set to change.

Product coverage:
NRT gum, NRT patches, NRT inhalators, other

Data coverage:
indsutry size (historic and projections ), market shares , brand shares

Reasons to Buy This Report
* Gain in-depth understanding of the smoking cessation aids market
* Pinpoint growth segments and trends and identify factors driving change
* Get a full overview of the competitive landscape , the industry ’s major players and leading brands
* Anticipate market change with 5 year forecasts

Alternative Medicine Industry in Brazil

Nrt Smoking Cessation Aids in Brazil

February 2010
List of Contents and Tables
Executive Summary
Consumer Healthcare Remains Resilient Despite the Economic Slowdown
Anvisa Moves OTC Products Behind-the-counter
Pharmaceutical Market Moving Towards Consolidation
Parapharmacies/drugstores Dominate Sales of OTC Products
Further Investment From Multinational Players
Key Trends and Developments
OTC Products Moved Behind-the-counter
Anvisa Approves New Rules for Advertising and Suspends Advertising of Analgesics
Pharmaceutical Market Moving Towards Consolidation
OTC Segment Remains Resilient During Economic Slowdown
Market Indicators
Data table 1 Consumer Expenditure on Health Goods and Medical Services from 2004 to 2009
Data table 2 Life Expectancy at Birth from 2004 to 2009
Market Data
Data table 3 Sales of Consumer Health by Segment : Value from 2004 to 2009
Data table 4 Sales of Consumer Health by Segment : % Value Growth from 2004 to 2009
Data table 5 Consumer Health Market Shares by Value from 2005 to 2009
Data table 6 Consumer Health Brand Shares by Value from 2006 to 2009
Data table 7 Sales of Consumer Health by Distribution Format: % Analysis from 2004 to 2009
Data table 8 Sales of Consumer Health by Segment and Distribution Format: % Analysis 2009
Data table 9 Projection Sales of Consumer Health by Segment : Value from 2009 to 2014
Data table 10 Projection Sales of Consumer Health by Segment : % Value Growth from 2009 to 2014
Appendix
OTC Registration and Classification
De-reimbursement
Generics
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches from 2007 to 2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Aché Laboratórios Farmacêuticos SA
Strategic Direction
Key Facts
Summary 3 Aché Laboratórios Farmacêuticos SA: Key Facts
Summary 4 Aché Laboratórios Farmacêuticos SA: Operational Indicators
Company Background
Production
Summary 5 Aché Laboratórios Farmacêuticos SA: Production Statistics 2009
Competitive Positioning
Summary 6 Aché Laboratórios Farmacêuticos SA: Competitive Position 2009
Bayer (brasil) SA
Strategic Direction
Key Facts
Summary 7 Bayer SA: Key Facts
Summary 8 Bayer SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Bayer SA: Competitive Position 2009
Boehringer Ingelheim Do Brasil Química E Farmacêutica Ltda
Strategic Direction
Key Facts
Summary 10 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts
Summary 11 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Operational Indicators
Company Background
Production
Summary 12 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2009
Competitive Positioning
Summary 13 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2009
Cadbury Adams Brasil Indústria E Comércio De Produtos Alimentícios Ltda
Strategic Direction
Key Facts
Summary 14 Cadbury Adams Indústria e Comércio Alimentícios Ltda: Key Facts
Company Background
Production
Competitive Positioning
Summary 16 Cadbury Adams Indústria e Comércio Alimentícios Ltda: Competitive Position 2009
Ems SA
Strategic Direction
Key Facts
Summary 17 EMS SA: Key Facts
Summary 18 EMS SA: Operational Indicators
Company Background
Production
Summary 19 EMS SA: Production Statistics 2009
Competitive Positioning
Summary 20 EMS SA: Competitive Position 2009
Eurofarma Laboratório Ltda
Strategic Direction
Key Facts
Summary 21 Eurofarma Laboratório Ltda: Key Facts
Summary 22 Eurofarma Laboratório Ltda: Operational Indicators
Company Background
Production
Summary 23 Eurofarma Laboratório Ltda: Production Statistics 2009
Competitive Positioning
Summary 24 Eurofarma Laboratório Ltda: Competitive Position 2009
Hypermarcas SA
Strategic Direction
Key Facts
Summary 25 Hypermarcas SA: Key Facts
Summary 26 Hypermarcas SA: Operational Indicators
Company Background
Production
Summary 27 Hypermarcas SA: Production Statistics 2009
Competitive Positioning
Summary 28 Hypermarcas SA: Competitive Position 2009
Medley SA Indústria Farmacêutica
Strategic Direction
Key Facts
Summary 29 Medley SA Indústria Farmacêutica: Key Facts
Summary 30 Medley SA Indústria Farmacêutica: Operational Indicators
Company Background
Production
Summary 31 Medley SA Indústria Farmacêutica: Production Statistics 2009
Competitive Positioning
Summary 32 Medley SA Indústria Farmacêutica: Competitive Position 2009
Nycomed Pharma Ltda
Strategic Direction
Key Facts
Summary 33 Nycomed Pharma Ltda: Key Facts
Summary 34 Nycomed Pharma Ltda: Operational Indicators
Company Background
Production
Summary 35 Nycomed Pharma Ltda: Production Statistics 2009
Competitive Positioning
Summary 36 Nycomed Pharma Ltda: Competitive Position 2009
Sanofi-aventis Farmacêutica Ltda
Strategic Direction
Key Facts
Summary 37 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Summary 38 Sanofi-Aventis Farmacêutica Ltda: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 39 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Indicators
Data table 11 Number of Smokers by Gender from 2004 to 2009
Category Data
Data table 12 Sales of Smoking Cessation Aids by Subsector: Value from 2004 to 2009
Data table 13 Sales of Smoking Cessation Aids by Subsector: % Value Growth from 2004 to 2009
Data table 14 NRT Gum Flavours: % Value Breakdown from 2006 to 2009
Data table 15 Smoking Cessation Aids Market Shares by Value from 2005 to 2009
Data table 16 Smoking Cessation Aids Brand Shares by Value from 2006 to 2009
Data table 17 Projection Sales of Smoking Cessation Aids by Subsector: Value from 2009 to 2014
Data table 18 Projection Sales of Smoking Cessation Aids by Subsector: % Value Growth from 2009 to 2014